Ordering RecommendationRecommendations when to order or not order the test. May include related or preferred tests.
Not recommended for routine detection of Chlamydia trachomatis (CT). Use to detect CT in medicolegal settings and to assess suspected treatment failure. May be considered for anatomic locations for which amplified testing has not been validated.
MnemonicUnique test identifier.
CHLAM
MethodologyProcess(es) used to perform the test.
Cell Culture/Immunofluorescence
PerformedDays of the week the test is performed.
Sun-Sat
ReportedExpected turnaround time for a result, beginning when ARUP has received the specimen.
2-5 days
New York DOH Approval StatusIndicates test has been approved by the New York State Department of Health.
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect
Cervical, eye, rectal, urethral swab, or peritoneal fluid. Also acceptable for newborns: Nasopharyngeal aspirate, swab or washing.
Specimen Preparation
Immediately place swab, fluid, or washing in 3 mL universal transport medium such as M4, M4RT, M5, M6, UniTranz-RT, or UTM (ARUP supply #12884). Available online through eSupply using ARUP Connect or contact ARUP Client Services at (800) 522-2787.
Storage/Transport Temperature
Frozen on dry ice.
Unacceptable Conditions
Urine. Specimens in any transport media other than indicated. Calcium alginate, dry, or wood swabs.
Remarks
Specimen source preferred.
Stability
Ambient: 1 hour; Refrigerated: 48 hours; Frozen at -20°C: Unacceptable; Frozen at -70°C: 1 month
Reference IntervalNormal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Culture negative for Chlamydia trachomatis.
Interpretive DataBackground information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Compliance Category
FDA
NoteAdditional information related to the test.
Nucleic acid amplification testing is recommended for detection of Chlamydia trachomatis from endocervical or urethral specimens. Refer to Chlamydia trachomatis by Transcription-Medicated Amplification (TMA) (ARUP test code 0060243). Specimen must be collected and transported with test-specific kit (ARUP supply #55224).
Positive Chlamydia cultures are confirmed for trachomatis by Chlamydia trachomatis by Transcription-Mediated Amplification (TMA) at no additional charge. Some specimen types acceptable for the Chlamydia trachomatis Culture may require a disclaimer for the TMA confirmation assay.
Hotline History
N/A
CPT CodesThe American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
AliasesOther names that describe the test. Synonyms.
Chat
Feedback
